Recession fears compounded final week, following actions from the Federal Reserve and different central banks to tame inflation, together with the discharge of downbeat U.S. financial information. Those considerations pushed the S & P 500 into bear market territory, closing Friday’s session down 23.7% from its January file. The Dow Jones Industrial Average closed out the week down 19.1% from its all-time excessive, simply outdoors of a bear market. All that mentioned, Morgan Stanley highlighted some shares it thinks are geared up to climate one of these storm. Strategists on the financial institution screened the Russell 1000 index — excluding financials, actual property and utilities — for corporations with robust stability sheets. Here are the factors used for the display: Cash as a p.c of enterprise worth of greater than 3% More than 5% free money move development anticipated by analysts in every of the subsequent two years Return on invested capital anticipated in every of the subsequent two years of greater than 10% Assets-to-liabilities a number of of greater than 1 Debt-to-equity ratio of lower than 2.5 This display contains solely shares which have funding grade credit score scores and excludes names with unfavorable fairness. Check out 10 names that made the checklist: Micron made Morgan Stanley’s checklist, with money as a p.c of enterprise worth at 12.2%. The chipmaker’s free money move can also be anticipated to greater than double subsequent 12 months and develop by almost 52% the 12 months after that. The firm’s inventory has struggled this 12 months, falling roughly 40% in that point. Howe ver, UBS final week reiterated it as a prime decide , noting that firm particular and business elements ought to help its margins. “Amid macro concerns, we believe investors continue to overlook several key factors,” analyst Tim Arcuri wrote. “Although end market weakness in PC/smartphones is weighing somewhat on near term DRAM ASPs, we see very strong pricing support heading into C2023 as the industry growth in bit supply is set to compress significantly.” United Therapeutics topped Morgan Stanley’s checklist, with money as a p.c of enterprise worth at 24.9%. Analysts additionally count on double-digit free money move development within the subsequent two years and see return on funding capital at 14.3% and 13.5% throughout these years. Shares of the biotech firm have outperformed the market in 2022, eking out a slight acquire in that point. The inventory can also be up 20% over the previous 12 months. Shoemaker Skechers additionally made the minimize, with 8.5% money as a p.c of enterprise worth. The firm’s free money move is predicted to develop by simply 7.1% subsequent 12 months, but it surely’s forecast to leap by 72.5% the 12 months after. The inventory is down about 16% in 2022, outperforming the S & P 500. Argus Research upgraded it to purchase from maintain final week, noting that the corporate’s “supply-chain initiatives and strong brand are likely to boost revenue and earnings over the next two years.” Google-parent Alphabet can also be on the checklist, sporting money as a p.c of enterprise worth of seven.2%. The firm’s free money move can also be anticipated to develop by 13.4% and 17.7% in every of the subsequent two years. Alphabet shares have fallen 26% this 12 months, as buyers have broadly dumped expertise names within the face of rising charges. Other shares that made the checklist are: Arista Networks , Johnson & Johnson , Merck , Five Below , Jabil and Emerson Electric . —CNBC’s Michael Bloom contributed to this report.